Status:
COMPLETED
Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®
Lead Sponsor:
Allergan
Conditions:
Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Comparing Safety and Efficacy of Combigan® and Lumigan® with Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated with Xalatan®.
Eligibility Criteria
Inclusion
- Diagnosed with glaucoma or ocular hypertension.
- Visual Acuity 20/100 or better in both eyes
Exclusion
- Any active ocular disease
- History of any intraocular surgery or glaucoma laser surgery within 3 months
- Contraindication to pupil dilation
- Use of topical, periorbital, intravitreal, or systemic steroid within 3 months
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT01170884
Start Date
December 1 2009
End Date
September 1 2010
Last Update
April 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dallas, Texas, United States